𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Potent and Selective Inhibition of Acid Sphingomyelinase by Bisphosphonates

✍ Scribed by Anke G. Roth; Daniela Drescher; Yang Yang; Susanne Redmer; Stefan Uhlig; Christoph Arenz

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
353 KB
Volume
48
Category
Article
ISSN
0044-8249

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type selective inhibition of microbial f
Type selective inhibition of microbial fatty acid synthases by thiolactomycin
✍ Nariaki Arimura; Toshi Kaneda 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 321 KB

The antibiotic, thiolactomycin, is known to selectively inhibit the Type II straight-chain fatty acid synthase (monofunctional enzyme system, e.g. Escherichia coli enzyme) but not Type I straight-chain fatty acid synthase (multifunctional enzyme system, e.g. Saccharomyces cerevisiae enzyme). We have

The bisphosphonate zoledronic acid has a
The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation
✍ Andreas Guenther; Sharon Gordon; Markus Tiemann; Renate Burger; Frank Bakker; Jo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 306 KB

## Abstract Nitrogen‐containing bisphosphonates (N‐BPs) are effective antiosteolytic agents in patients with multiple myeloma. Preclinical studies have also demonstrated that these agents have direct antitumor effects __in vitro__ and can reduce tumor burden in a variety of animal models, although